Skip to main navigation Skip to search Skip to main content

LRRK2 and the immune system

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Polymorphisms in leucine-rich repeat kinase 2 (LRRK2) have been linked to familial Parkinson’s disease, increased risk of sporadic Parkinson’s disease, increased risk of Crohn’s inflammatory bowel disease, and increased susceptibility to leprosy. As well as LRRK2 mutations, these diseases share in common immune dysfunction and inflammation. LRRK2 is highly expressed in particular immune cells and has been biochemically linked to the intertwined pathways regulating inflammation, mitochondrial function, and autophagy/lysosomal function. This review outlines what is currently understood about LRRK2 function in the immune system and the potential implications of LRRK2 dysfunction for diseases genetically linked to this enigmatic enzyme.

Original languageEnglish
Title of host publicationLeucine-Rich Repeat Kinase 2 (LRRK2)
EditorsHardy J. Rideout
Place of PublicationCham
PublisherSpringer, Springer Nature
Chapter7
Pages123-143
Number of pages21
ISBN (Electronic)9783319499697
ISBN (Print)9783319499673
DOIs
Publication statusPublished - 1 Apr 2017
Externally publishedYes

Publication series

NameAdvances in Neurobiology
PublisherSpringer
Volume14
ISSN (Print)2190-5215
ISSN (Electronic)2190-5223

Keywords

  • Crohn’s disease
  • Cytokine
  • Inflammation
  • Innate immunity
  • Kinase
  • Parkinson’s disease

Fingerprint

Dive into the research topics of 'LRRK2 and the immune system'. Together they form a unique fingerprint.

Cite this